- Home
- WAT vs COO Comparison
WAT vs COO Comparison
Compare WAT & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAT
- COO
- Stock Information
- Founded
- WAT 1958
- COO 1980
- Country
- WAT United States
- COO United States
- Employees
- WAT N/A
- COO N/A
- Industry
- WAT Biotechnology: Laboratory Analytical Instruments
- COO Ophthalmic Goods
- Sector
- WAT Industrials
- COO Health Care
- Exchange
- WAT Nasdaq
- COO Nasdaq
- Market Cap
- WAT 17.8B
- COO 14.6B
- IPO Year
- WAT 1995
- COO N/A
- Fundamental
- Price
- WAT $309.50
- COO $68.72
- Analyst Decision
- WAT Hold
- COO Buy
- Analyst Count
- WAT 14
- COO 9
- Target Price
- WAT $374.07
- COO $80.33
- AVG Volume (30 Days)
- WAT 563.4K
- COO 3.2M
- Earning Date
- WAT 10-31-2025
- COO 08-27-2025
- Dividend Yield
- WAT N/A
- COO N/A
- EPS Growth
- WAT 10.77
- COO 13.33
- EPS
- WAT 11.09
- COO 2.04
- Revenue
- WAT $3,046,056,000.00
- COO $4,045,700,000.00
- Revenue This Year
- WAT $7.19
- COO $6.84
- Revenue Next Year
- WAT $6.40
- COO $6.54
- P/E Ratio
- WAT $27.91
- COO $33.38
- Revenue Growth
- WAT 5.89
- COO 6.35
- 52 Week Low
- WAT $275.05
- COO $61.78
- 52 Week High
- WAT $423.56
- COO $112.38
- Technical
- Relative Strength Index (RSI)
- WAT 58.10
- COO 45.15
- Support Level
- WAT $286.14
- COO $61.78
- Resistance Level
- WAT $302.94
- COO $67.55
- Average True Range (ATR)
- WAT 8.17
- COO 2.03
- MACD
- WAT 2.35
- COO -0.42
- Stochastic Oscillator
- WAT 97.05
- COO 50.94
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
About COO The Cooper Companies Inc.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.